menu search

PRPH / ProPhase Labs, Inc. (PRPH) Surges 8.5%: Is This an Indication of Further Gains?

ProPhase Labs, Inc. (PRPH) Surges 8.5%: Is This an Indication of Further Gains?
ProPhase Labs, Inc. (PRPH) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term. Read More
Posted: May 3 2023, 05:20
Author Name: Zacks Investment Research
Views: 110175

PRPH News  

ProPhase Labs, Inc. (PRPH) Q2 2023 Earnings Call Transcript

By Seeking Alpha
August 12, 2023

ProPhase Labs, Inc. (PRPH) Q2 2023 Earnings Call Transcript

ProPhase Labs, Inc. (NASDAQ:PRPH ) Q2 2023 Earnings Conference Call August 10, 2023 11:00 AM ET Company Participants Ted Karkus - Chairman and CEO Con more_horizontal

ProPhase Labs Announces Updated Conference Call Dial-in Information for Thursday August 10, 2023 at 11:00 a.m. Eastern Time for Second Quarter 2023 Financial Results Call.

By GlobeNewsWire
August 10, 2023

ProPhase Labs Announces Updated Conference Call Dial-in Information for Thursday August 10, 2023 at 11:00 a.m. Eastern Time for Second Quarter 2023 Financial Results Call.

Garden City, NY, Aug. 10, 2023 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) Conference Call and Webcast Details Management will host a confe more_horizontal

ProPhase Labs to Host Second Quarter 2023 Financial Results Conference Call on Thursday, August 10, 2023 at 11:00 a.m. Eastern Time

By GlobeNewsWire
August 2, 2023

ProPhase Labs to Host Second Quarter 2023 Financial Results Conference Call on Thursday, August 10, 2023 at 11:00 a.m. Eastern Time

GARDEN CITY, NY, Aug. 02, 2023 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a next generation biotech, genomics, therapeutics and diagnost more_horizontal

ProPhase Labs Continues To Make The Right Moves - Reiterate Strong Buy

By Seeking Alpha
June 11, 2023

ProPhase Labs Continues To Make The Right Moves - Reiterate Strong Buy

ProPhase Labs thrived in the Covid era and then wisely used the gains to invest in new testing capabilities including whole genome sequencing and a ne more_horizontal

ProPhase Labs, Inc. (PRPH) Surges 8.5%: Is This an Indication of Further Gains?

By Zacks Investment Research
May 3, 2023

ProPhase Labs, Inc. (PRPH) Surges 8.5%: Is This an Indication of Further Gains?

ProPhase Labs, Inc. (PRPH) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might n more_horizontal

ProPhase Labs, Inc. (PRPH) Soars 7.5%: Is Further Upside Left in the Stock?

By Zacks Investment Research
April 10, 2023

ProPhase Labs, Inc. (PRPH) Soars 7.5%: Is Further Upside Left in the Stock?

ProPhase Labs, Inc. (PRPH) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might h more_horizontal

ProPhase Labs: Lots Of Moving Pieces

By Seeking Alpha
March 2, 2023

ProPhase Labs: Lots Of Moving Pieces

Medical diagnostic and testing concern ProPhase Labs, Inc. gets put in the spotlight today. ProPhase Labs, Inc. has seen huge revenue growth from Covi more_horizontal

ProPhase Labs to Present at the Planet MicroCap Showcase: VIRTUAL 2022 on Wednesday, December 7, 2022

By GlobeNewsWire
November 30, 2022

ProPhase Labs to Present at the Planet MicroCap Showcase: VIRTUAL 2022 on Wednesday, December 7, 2022

GARDEN CITY, NY, Nov. 30, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a growth oriented and diversified diagnostics, genomics and bio more_horizontal


Search within

Pages Search Results: